Methylbenzodioxolylbutanamine

Methylbenzodioxolylbutanamine
Systematic (IUPAC) name
(RS)-1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 103818-46-8 YesY
ATC code  ?
PubChem CID 124844
Chemical data
Formula C12H17NO2 
Mol. mass 207.27 g/mol
SMILES eMolecules & PubChem
Physical data
Melt. point 156 °C (313 °F)
 YesY(what is this?)  (verify)

Methylbenzodioxolylbutanamine (MBDB; Methyl-J; "Eden") is an entactogen of the phenethylamine chemical class. MBDB is a closely related chemical analogue of MDMA, with the only difference between the two molecules being an ethyl group instead of a methyl group attached to the alpha carbon.

MBDB was first synthesized by David E. Nichols[citation needed], a leading pharmacologist and medicinal chemist, and later tested by Alexander Shulgin and described in his book, PiHKAL: A Chemical Love Story. MBDB's dosage, according to PiHKAL, is 180–210 mg; the proper dosage relative to body mass seems unknown. Its duration is 4–6 hours, with noticeable after-effects lasting for 1–3 hours.

MBDB was initially developed as a non-psychedelic entactogen. It has lower effects on the dopamine system in comparison to other entactogens such as MDMA. MBDB causes many mild, MDMA-like effects, such as lowering of social barriers and inhibitions, pronounced sense of empathy and compassion, mood lift, and mild euphoria are all present. MBDB tends to produce less euphoria, psychedelia, and stimulation in comparison. Many users declare that MBDB is a "watered-down" version of MDMA. Despite these features which make MBDB less desirable as a recreational drug, it has been suggested that the drug may have greater therapeutic potential than MDMA.

Unlike MDMA, MBDB is not internationally scheduled under the United Nations Convention on Psychotropic Substances. The thirty-second meeting of the WHO Expert Committee on Drug Dependence (September 2000) evaluated MBDB and recommended against scheduling.[1] From the WHO Expert Committee assessment of MBDB:

Although MBDB is both structurally and pharmacologically similar to MDMA, the limited available data indicate that its stimulant and euphoriant effects are less pronounced than those of MDMA. There have been no reports of adverse or toxic effects of MBDB in humans. Law enforcement data on illicit trafficking of MBDB in Europe suggest that its availability and abuse may now be declining after reaching a peak during the latter half of the 1990s. For these reasons, the Committee did not consider the abuse liability of MBDB would constitute a significant risk to public health, thereby warranting its placement under international control. Scheduling of MBDB was therefore not recommended.

See also

References

  1. ^ WHO Expert Committee on Drug Dependence, Thirty-second Report, Technical Report Series 903 (2001)

External links



Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Empathogen-entactogen — The terms empathogen and entactogen are used to describe a class of psychoactive drugs that produce distinctive emotional and social effects similar to those of MDMA. Putative members of this class include 2C B, 2C I, MDMA, MDA, MDEA, MBDB, 2C T… …   Wikipedia

  • Methylbenzodioxolylpentanamine — IUPAC name 1 (1,3 benzodioxol 5 yl) N methylpentan 2 amine …   Wikipedia

  • Ethylbenzodioxolylbutanamine — IUPAC name (1 Benzo[1,3]dioxol 5 ylmethyl propyl) ethyl amine …   Wikipedia

  • Amphetamine — For other uses, see Amphetamine (disambiguation). Amphetamine Systematic (IUPAC) name …   Wikipedia

  • Antipsychotic — Advertisement for Thorazine (chlorpromazine) from the 1950s[1] An antipsychotic (or neuroleptic) is a tranquilizing psychiatric medication primarily used to manage psychosis (including delusions or hallucinations, as well as disordered tho …   Wikipedia

  • Dimethyltryptamine — Systematic (IUPAC) name 2 (1H indol 3 yl) N …   Wikipedia

  • Modafinil — Systematic (IUPAC) name (±) 2 (benzhydrylsulfinyl)acetamide …   Wikipedia

  • Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… …   Wikipedia

  • Phencyclidine — Systematic (IUPAC) name …   Wikipedia

  • Phenothiazine — Phenothiazine …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.